This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Motor disorders
KRA_PSY_MOTOR
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
652 |
4. Check minimum number of eventsNone |
652 |
5. Include endpointsNone |
652 |
6. Filter based on genotype QC (FinnGen only) |
574 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F80-F89
- Name in latin
- Perturbatio specifica progressus functionis motoricae
Similar endpoints
↥List of similar endpoints to
Motor disorders
based on the number of shared cases.
Similar with more cases:
- Specific developmental disorder of motor function
- Motor disorders, excluding more controls
- Disorders of psychological development
- Any mental disorder
- Psychiatric diseases
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 574 | 239 | 335 |
| Unadjusted period prevalence (%) | 0.12 | 0.08 | 0.15 |
| Median age at first event (years) | 6.11 | 6.06 | 6.14 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 624
- Matched controls
- 6196
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F82
ICD-10 Finland
Specific developmental disorder of motor function
10266.4
307.7
588
6
F83
ICD-10 Finland
Mixed specific developmental disorders
11.6
142.7
170
193
R62.0
ICD-10 Finland
Delayed milestone
8.2
97.3
150
230
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
8.9
95.4
135
187
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
7.5
93.0
158
269
F80.1
ICD-10 Finland
Expressive language disorder
10.4
92.8
113
129
XA800
NOMESCO Finland
Neuropsychological investigation
7.1
92.6
169
310
Z2445
NOMESCO Finland
Psychologist
5.4
77.5
197
487
R4120
NOMESCO Finland
Occupational therapy
6.8
77.1
139
249
Z3226
NOMESCO Finland
Physiotherapist
4.2
65.9
262
906
F80.2
ICD-10 Finland
Receptive language disorder
9.3
65.1
84
102
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.8
64.5
188
513
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
9.6
57.1
71
82
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
8.3
51.1
71
94
Z2446
NOMESCO Finland
Social worker
3.6
42.9
190
679
R4110
NOMESCO Finland
Physiotherapy
3.2
42.7
250
1060
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.3
40.9
213
839
3154A
ICD-9 Finland
Specific delays in development, Coördination disorder
+∞
39.9
38
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.0
38.5
252
1127
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.2
38.1
201
793
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.6
37.4
100
248
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
5.0
37.3
89
201
Z2221
NOMESCO Finland
Medical doctor
3.0
37.2
236
1034
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
8.9
36.6
47
56
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
8.9
36.6
47
56
RT150, ,
NOMESCO Finland
7.8
36.2
52
71
RL140, ,
NOMESCO Finland
8.7
35.2
46
56
Z3231
NOMESCO Finland
Registered nurse
2.8
35.0
305
1572
Z3229
NOMESCO Finland
Other healthcare associate professional
3.7
34.2
126
394
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.3
33.6
160
589
F90.0
ICD-10 Finland
Disturbance of activity and attention
3.1
33.4
181
719
RT160, ,
NOMESCO Finland
8.7
33.1
43
52
ZXD10
NOMESCO Finland
Scheduled procedure
2.7
32.1
282
1444
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.9
31.9
75
167
N05AX08
ATC
risperidone; systemic
4.3
31.4
89
230
ZXE20
NOMESCO Finland
More than three and less than five hours
3.6
30.4
117
375
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.0
30.3
179
742
RL130, ,
NOMESCO Finland
7.4
28.1
42
60
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.4
27.4
115
388
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.7
27.4
96
288
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.4
27.3
110
362
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.8
27.3
66
150
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
7.2
26.8
41
60
R1250
NOMESCO Finland
Evaluation of functional capability
7.9
26.4
37
49
R1260
NOMESCO Finland
Evaluation of communicative skills
7.2
26.3
40
58
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
25.6
204
975
ZY010
NOMESCO Finland
Hospital outpatient
3.1
25.2
121
442
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
8.2
25.1
34
43
602
Kela drug reimbursment
Children's severe malnutrition
4.5
25.1
65
156
N05AH03
ATC
olanzapine; systemic
3.8
24.8
83
241
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.4
24.7
99
324
R5599
NOMESCO Finland
Other rehabilitation service
5.1
24.1
53
111
Z50.5
ICD-10 Finland
Speech therapy
3.7
23.7
81
238
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
4.1
23.7
69
181
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.3
23.4
99
334
F81.0
ICD-10 Finland
Specific reading disorder
5.6
22.4
44
83
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.2
22.4
63
161
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.8
22.1
74
214
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
8.3
21.7
29
36
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.9
21.5
68
189
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.0
21.5
107
397
ZXE00
NOMESCO Finland
One hour or less
2.2
21.3
287
1704
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
6.1
20.9
37
63
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
6.3
20.8
36
60
Z31.5
ICD-10 Finland
Genetic counselling
3.1
20.7
96
342
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.7
20.5
49
110
Z01.8
ICD-10 Finland
Other specified special examinations
2.5
20.2
158
739
WX730
NOMESCO Finland
Conventional respirator
8.6
20.1
26
31
P07.2
ICD-10 Finland
Extreme immaturity
24.2
20.0
28
12
F20.9
ICD-10 Finland
Schizophrenia, unspecified
7.8
19.9
28
37
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
19.9
139
615
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.2
19.4
82
276
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
5.1
19.3
42
87
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.9
19.1
102
392
N03AG01
ATC
valproic acid; systemic, rectal
3.6
18.8
67
202
A28
ICPC
Limited function/disability NOS
3.4
18.7
74
239
N05AH02
ATC
clozapine; systemic
6.4
18.5
31
50
N05AX12
ATC
aripiprazole; systemic
3.4
18.3
70
221
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
25.8
18.3
25
10
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
18.3
145
679
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.5
18.2
67
206
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
18.2
145
680
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
18.2
230
1312
ZXA00
NOMESCO Finland
Right side
2.7
17.3
105
431
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.6
17.1
28
44
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
15.8
16.2
26
17
R4130
NOMESCO Finland
Speech therapy
3.6
15.7
55
164
N05AH04
ATC
quetiapine; oral
2.3
15.2
142
710
H01AC01
ATC
somatropin; parenteral
3.7
15.0
50
144
RS222, ,
NOMESCO Finland
4.8
15.0
34
73
N06BA04
ATC
methylphenidate; oral
2.3
14.9
131
638
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
14.7
205
1196
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
14.6
111
506
RF120, ,
NOMESCO Finland
11.2
14.6
27
25
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
4.8
14.5
33
71
K03.66
ICD-10 Finland
Tooth plaque
2.2
14.5
147
759
H52.2
ICD-10 Finland
Astigmatism
3.3
14.2
55
175
F84.5
ICD-10 Finland
Asperger syndrome
4.7
14.0
33
73
XX4AW, ,
NOMESCO Finland
3.9
13.8
41
109
N03AX14
ATC
levetiracetam; systemic
3.9
13.6
41
110
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.7
13.4
44
125
SPAT1229
SPAT
Assessment of need for aid
5.7
13.3
25
45
N05AA02
ATC
levomepromazine; systemic
5.2
13.1
27
53
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
4.6
13.1
31
69
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
5.6
13.0
25
46
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.4
13.0
95
424
WX722
NOMESCO Finland
PEEP
4.0
13.0
37
95
F93.89
ICD-10 Finland
Other childhood emotional disorders
3.2
12.9
52
169
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.8
12.9
68
258
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
5.1
12.9
27
54
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
5.1
12.9
27
54
R5140
NOMESCO Finland
Monitoring the use of the aid
4.2
12.6
34
84
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.8
12.3
28
60
WX882
NOMESCO Finland
High dependency care
2.4
12.2
88
390
J45.1
ICD-10 Finland
Nonallergic asthma
2.4
12.2
93
423
183
Kela drug reimbursment
Lamotrigin and topiramate
5.2
12.2
25
49
F88
ICD-10 Finland
Other disorders of psychological development
4.5
12.2
30
69
C03CA01
ATC
furosemide; systemic
3.4
12.1
44
134
AA1AD
NOMESCO Finland
CT of head and brain
2.5
12.0
81
348
H50.30
ICD-10 Finland
Intermittent esotropy
4.5
11.9
29
66
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.4
11.9
90
408
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
11.9
59
217
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.5
11.8
41
121
H50.0
ICD-10 Finland
Convergent concomitant strabismus
4.3
11.8
31
75
FM2CE, ,
NOMESCO Finland
2.6
11.7
72
296
ZXA05
NOMESCO Finland
Left side
2.4
11.6
90
412
L02AE02
ATC
leuprorelin; implant, parenteral
8.8
11.6
24
28
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.9
11.5
58
215
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
4.4
11.5
29
68
RD210, ,
NOMESCO Finland
2.7
11.4
62
239
N03AX09
ATC
lamotrigine; oral
3.0
11.4
52
182
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
11.4
126
667
P85
ICPC
Mental retardation
4.2
11.4
31
77
RS211, ,
NOMESCO Finland
4.8
11.2
25
53
301
Kela drug reimbursment
Growth hormone
4.8
11.2
25
53
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.8
11.1
34
92
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
5.4
11.0
22
42
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
11.0
149
848
F84.8
ICD-10 Finland
Other pervasive developmental disorders
4.9
10.9
24
50
ZYC01
NOMESCO Finland
Remote contact by phone
2.6
10.9
68
281
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
10.8
57
216
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
10.8
114
592
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.5
10.8
73
314
R11
ICD-10 Finland
Nausea and vomiting
2.2
10.8
97
473
ZXD20
NOMESCO Finland
Day surgery
2.5
10.7
74
321
T90
ICPC
Diabetes non-insulin dependent
3.4
10.7
39
119
RT490, ,
NOMESCO Finland
5.7
10.7
20
36
RS220, ,
NOMESCO Finland
3.8
10.6
32
86
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.3
10.5
90
430
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
10.4
76
338
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
8.3
10.3
22
27
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
10.8
10.3
19
18
H35.1
ICD-10 Finland
Retinopathy of prematurity
19.0
10.3
15
8
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
10.1
71
310
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.2
10.1
40
129
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.4
10.1
75
337
H53.0
ICD-10 Finland
Amblyopia ex anopsia
3.4
10.0
36
109
N05CD08
ATC
midazolam; nasal, systemic
3.2
10.0
40
130
N05BA09
ATC
clobazam; oral
3.8
9.9
30
81
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.5
9.8
67
289
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
3.2
9.8
39
126
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.7
9.7
54
211
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.4
9.7
72
323
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
15.2
9.5
15
10
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
4.7
9.5
22
48
WX002
NOMESCO Finland
Sedation and analgesia
2.3
9.4
75
347
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
30.3
9.4
12
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
5.2
9.3
19
37
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.1
9.3
39
130
RF210, ,
NOMESCO Finland
4.4
9.3
23
53
ZX108
NOMESCO Finland
Inhalation
5.0
9.3
20
41
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
9.6
9.3
18
19
ZXD05
NOMESCO Finland
Urgent procedure
1.9
9.2
149
896
SPAT1234
SPAT
Support of social functional capacity
4.0
9.1
26
67
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
2.4
9.1
64
280
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
9.1
53
212
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.6
9.1
30
86
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
3.6
9.1
30
86
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
7.2
9.0
21
30
RF420, ,
NOMESCO Finland
9.2
9.0
18
20
ZXA10
NOMESCO Finland
Bilateral
2.0
9.0
116
645
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.3
9.0
74
347
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.1
8.9
86
430
H50.31
ICD-10 Finland
Intermittent exotropia
3.3
8.9
33
102
P72
ICPC
Schizophrenia
6.7
8.7
21
32
XCK00
NOMESCO Finland
Perimetry
4.3
8.6
22
52
BF20A, ,
NOMESCO Finland
16.4
8.5
13
8
RT422, ,
NOMESCO Finland
20.2
8.5
12
6
G47.3
ICD-10 Finland
Sleep apnoea
2.4
8.4
58
252
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
12.9
8.4
14
11
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
2.6
8.2
48
193
N05BA01
ATC
diazepam; systemic, rectal
2.5
8.1
52
218
P07.02
ICD-10 Finland
Extremely low birth weight 750-999 g
33.6
8.1
10
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.1
8.0
22
55
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
4.1
8.0
22
55
RS312, ,
NOMESCO Finland
10.1
8.0
15
15
P07.01
ICD-10 Finland
Extremely low birth weight 500-749 g
22.2
8.0
11
5
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
8.0
165
1062
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.5
7.9
52
221
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
4.7
7.8
18
39
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
8.5
7.8
16
19
Q38.1
ICD-10 Finland
Ankyloglossia
3.3
7.8
29
90
F39
ICD-10 Finland
Unspecified mood [affective] disorder
3.4
7.8
28
85
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
9.5
7.8
15
16
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
3.7
7.7
24
66
A03FA02
ATC
cisapride; oral, rectal
3.0
7.7
33
112
E66.01
ICD-10 Finland
Obesity due to excess calories
2.2
7.6
65
310
N03AF02
ATC
oxcarbazepine; oral
2.8
7.6
37
135
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
12.0
7.6
13
11
R27.0
ICD-10 Finland
Ataxia, unspecified
25.2
7.6
10
*
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
3.0
7.6
33
113
XG413
NOMESCO Finland
Spirometry with oscillometry
3.1
7.5
31
103
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.6
7.5
220
1550
EJC20
NOMESCO Finland
Operation on frenulum of tongue
3.7
7.4
23
63
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
80.4
7.4
8
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
7.4
36
131
N28
ICPC
Limited function/disability (N)
7.7
7.4
16
21
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
7.4
118
702
N05BA06
ATC
lorazepam; systemic, sublingual
6.0
7.4
19
32
L28
ICPC
Limited function/disability (L)
2.4
7.3
53
235
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
11.0
7.3
13
12
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
+∞
7.3
7
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.8
7.1
35
128
P07.3
ICD-10 Finland
Other preterm infants
2.6
7.1
40
157
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
4.0
7.1
20
51
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
7.1
133
828
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
3.2
7.1
28
90
ZX114
NOMESCO Finland
Intramuscular
3.6
7.1
23
65
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
8.0
7.1
15
19
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
7.1
175
1177
H81
ICPC
Excessive ear wax
2.2
7.0
62
299
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
7.1
7.0
16
23
ZX199
NOMESCO Finland
Other rote
4.3
7.0
18
43
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
3.5
7.0
24
71
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.4
6.9
46
196
UGC02
NOMESCO Finland
Rigid bronchoscopy
4.4
6.9
17
39
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.7
6.9
37
142
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
2.6
6.9
38
148
EMB30
NOMESCO Finland
Adenotomy
1.8
6.9
123
756
N06AB10
ATC
escitalopram; oral
1.8
6.9
124
764
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.2
6.9
27
87
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
2.9
6.8
31
109
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
11.0
6.8
12
11
E22.80
ICD-10 Finland
Central precocious puberty
9.4
6.8
13
14
201
Kela drug reimbursment
Chronic cardiac insufficiency
3.7
6.7
21
58
K07.24
ICD-10 Finland
Open bite
2.6
6.7
39
156
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.6
6.7
39
156
F89
ICD-10 Finland
Unspecified disorder of psychological development
3.9
6.7
19
49
XF404
NOMESCO Finland
Ambulatory ECG
2.4
6.6
44
188
P22.9
ICD-10 Finland
Respiratory distress of newborn, unspecified
4.1
6.6
18
45
TJD20
NOMESCO Finland
Change of gastrostomy tube
4.1
6.6
18
45
RF430, ,
NOMESCO Finland
12.3
6.6
11
9
101
Kela drug reimbursment
Anterior pituitary hypofunction
3.1
6.5
27
90
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
0.5
6.5
65
1160
P99
ICPC
Psychological disorders other
2.8
6.4
32
118
H52.0
ICD-10 Finland
Hypermetropia
2.4
6.4
43
184
SPAT1262
SPAT
Handing over of treatment supplies
2.2
6.4
56
269
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
6.4
83
461
RT130, ,
NOMESCO Finland
7.5
6.4
14
19
RS231, ,
NOMESCO Finland
14.4
6.4
10
7
Z07
ICPC
Education problem
2.8
6.3
32
119
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
2.1
6.3
58
284
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
6.3
33
125
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
4.1
6.3
17
42
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
5.2
6.3
18
35
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
5.6
6.3
17
31
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.6
6.3
20
56
Q04.8
ICD-10 Finland
Other specified congenital malformations of brain
18.1
6.3
9
5
FDE00
NOMESCO Finland
Closure of patent ductus arteriosus
18.1
6.3
9
5
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
6.2
111
680
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
6.2
50
232
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.9
6.2
18
47
H03AA01
ATC
levothyroxine sodium; systemic
2.1
6.2
62
314
Z71.8
ICD-10 Finland
Other specified counselling
1.5
6.2
244
1822
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.2
6.2
50
233
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
3.7
6.2
19
52
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
2.7
6.2
32
121
H50.1
ICD-10 Finland
Divergent concomitant strabismus
5.4
6.2
17
32
205
Kela drug reimbursment
Chronic hypertension
3.2
6.1
24
77
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.2
6.1
24
77
RS120, ,
NOMESCO Finland
5.8
6.1
16
28
B01AA03
ATC
warfarin; systemic
3.6
6.1
20
57
OAB43, ,
SPAT
0.6
6.1
114
1706
C03DA01
ATC
spironolactone; oral
2.6
6.1
33
128
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
4.2
6.1
16
39
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.6
6.0
35
140
UKC02
NOMESCO Finland
Cystoscopy
2.8
6.0
30
111
N88
ICPC
Epilepsy
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
346
2149
2.34
23.80
22.5
14.8
1.22
1.23
mmol/l
1.63
338
2057
356
2283
2.28
22.10
18.2
13.3
1.22
1.22
mmol/l
1.24
338
2115
412
2874
2.25
19.92
8.4
6.7
121.84
114.51
u/l
0.98
394
2730
29
50
5.99
16.16
17.3
20.7
18757.45
661.16
nmol/l
0.49
29
50
257
1591
2.03
15.84
10.2
9.1
38.36
38.44
g/l
0.08
244
1533
281
1800
2.00
15.68
10.0
8.7
22.53
19.94
umol/l
0.42
266
1676
311
2104
1.93
14.43
5.3
3.8
67.49
66.32
nmol/l
0.34
301
2002
200
1176
2.01
13.88
3.3
3.1
2.38
2.40
mmol/l
1.70
190
1098
108
502
2.37
13.55
18.4
16.0
106.31
105.23
mmol/l
1.18
108
502
49
151
3.41
13.25
2.5
3.9
4.40
7.79
index
0.61
30
105
153
842
2.07
12.58
3.7
2.5
273.34
494.94
u/l
1.14
153
818
75
309
2.60
12.13
29.7
18.1
-0.62
-0.12
mmol/l
0.44
64
262
176
1036
1.96
11.90
16.3
12.6
1.31
1.33
mmol/l
0.41
168
995
356
2653
1.77
10.93
14.7
8.8
5.98
6.05
mmol/l
0.23
340
2467
535
4549
2.18
10.64
25.6
13.7
139.61
139.48
mmol/l
0.81
530
4430
230
1520
1.80
10.60
5.6
4.9
39.28
34.86
u/l
0.35
225
1461
535
4552
2.17
10.57
25.4
13.7
3.95
3.93
mmol/l
1.19
528
4409
120
648
2.04
10.21
7.7
7.8
6.20
6.80
umol/l
0.20
105
540
180
1124
1.83
9.89
11.3
11.4
0.73
1.06
mmol/l
0.69
149
926
129
731
1.95
9.53
18.0
13.5
0.80
0.81
mmol/l
0.67
124
706
417
3326
1.74
9.38
16.2
12.6
3.63
3.58
e9/l
0.18
370
2764
205
1356
1.75
9.15
4.5
4.9
8.08
9.04
mmol/l
1.37
187
1281
159
983
1.81
8.91
4.7
4.1
4.43
1.95
e6/l
1.78
89
517
179
1152
1.76
8.73
2.0
1.6
99.83
98.71
pmol/l
0.10
86
600
92
476
2.08
8.73
15.0
6.8
1146.40
1315.81
ng/l
0.12
72
389
457
3795
1.73
8.30
5.2
3.8
14.68
14.56
pmol/l
0.50
432
3491
119
692
1.87
8.04
4.1
3.3
2.62
2.54
g/l
0.95
109
667
125
747
1.83
7.73
4.1
3.2
12.49
14.18
umol/l
1.92
118
727
62
288
2.26
7.70
3.4
3.6
5.11
5.18
pmol/l
0.18
62
272
121
718
1.84
7.65
1.6
1.4
19.77
19.34
nmol/l
0.12
110
644
53
234
2.36
7.39
38.9
20.8
93.75
95.54
%
0.46
53
234
499
4300
1.76
7.33
5.8
4.3
2.01
1.92
mu/l
1.15
478
4086
169
1119
1.69
7.26
3.9
3.5
—
—
—
0
0
52
231
2.35
7.16
39.4
21.1
0.60
0.67
%
0.86
52
231
234
1691
1.60
7.06
6.2
4.8
—
—
—
0
0
87
476
1.95
7.03
2.9
2.3
4.42
5.81
u/l
1.65
62
287
172
1161
1.65
6.81
3.5
3.0
1.02
1.02
kg/l
0.85
115
697
404
3331
1.58
6.73
4.4
2.5
5.71
5.39
mmol/l
3.09
385
3089
550
4932
1.90
6.40
14.3
9.9
31.85
27.66
u/l
1.82
540
4806
149
985
1.66
6.35
4.9
3.9
0.50
0.64
e6/l
0.57
79
512
225
1651
1.55
6.18
6.0
4.6
10.28
42.43
e6/l
4.56
173
1225
156
1053
1.63
6.10
18.4
9.6
0.36
0.89
mmol/l
1.74
117
770
130
838
1.68
6.08
7.3
4.9
1.19
1.72
mg/l
0.80
99
585
103
627
1.76
5.91
5.6
3.5
778.92
1133.15
ng/l
0.49
68
325
384
3177
1.52
5.91
3.9
2.8
1.27
1.14
mmol/l
2.80
370
3042
377
3116
1.51
5.76
5.2
3.6
36.09
35.71
mmol/mol
0.27
368
3000
120
778
1.66
5.45
11.0
7.7
30.83
30.77
s
0.03
120
771
553
5020
1.82
5.43
18.0
11.1
60.45
62.76
umol/l
1.48
548
4937
41
186
2.27
5.42
13.0
11.9
22.76
23.30
mmol/l
0.64
41
177
239
1828
1.48
5.19
4.6
3.6
—
—
estimate
—
0
0
47
232
2.09
5.06
1.9
2.0
21.95
27.28
ng/l
0.44
47
232
15
40
3.79
5.06
2.2
1.5
0.67
0.86
iu/ml
—
9
19
75
435
1.81
5.06
3.1
2.3
5.98
6.72
iu/l
0.39
53
267
99
626
1.68
4.93
1.5
1.5
216.47
380.18
u/ml
0.80
92
597
56
298
1.95
4.92
10.0
16.2
130.80
129.06
g/l
0.23
56
291
15
33
4.60
4.86
2.1
1.6
0.16
0.23
iu/ml
—
10
19
52
273
1.97
4.75
1.6
1.8
—
—
—
0
0
411
3525
1.46
4.73
4.5
3.1
4.28
4.40
mmol/l
1.93
397
3397
88
547
1.70
4.67
2.8
2.3
10.02
11.01
nmol/l
0.38
83
509
72
427
1.76
4.51
14.8
10.8
93.50
92.59
%
0.14
72
427
80
491
1.71
4.45
2.7
2.0
—
—
—
0
0
139
979
1.53
4.40
18.2
9.6
9.65
9.81
kpa
0.43
134
952
79
485
1.71
4.39
2.9
2.1
—
—
—
0
0
200
1518
1.45
4.37
6.0
4.4
0.14
0.23
e6/l
0.70
144
1095
187
1402
1.46
4.36
2.1
1.9
1.49
1.29
mmol/l
2.17
175
1299
33
152
2.22
4.25
2.4
2.1
1.02
1.02
ratio
0.58
27
131
405
3501
1.42
4.20
4.5
3.1
2.65
2.69
mmol/l
0.38
393
3351
372
3173
1.41
4.13
11.0
7.5
112.39
109.88
ml/min/173m2
1.53
288
2484
48
258
1.92
4.12
10.4
16.3
0.63
0.61
%
0.15
48
258
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
117
2.35
4.00
33.4
25.4
0.32
0.34
iu/ml
0.33
17
72
146
1061
1.48
3.94
4.5
3.5
8.11
7.05
e6/l
0.33
133
959
401
3482
1.40
3.90
4.3
3.0
1.26
1.37
mmol/l
8.38
389
3335
71
440
1.68
3.82
2.2
2.0
2.41
2.41
mmol/l
0.14
58
380
8
252
0.31
3.79
1.5
1.8
—
—
—
0
0
539
4964
1.57
3.71
27.6
17.0
13.37
13.08
%
6.73
533
4900
112
782
1.51
3.66
2.2
1.7
1.69
1.38
%
0.62
103
708
41
218
1.93
3.65
4.7
3.6
—
—
—
0
0
28
132
2.16
3.45
2.5
1.7
—
—
—
0
0
36
187
1.97
3.44
2.0
1.4
—
—
—
0
0
72
462
1.62
3.40
2.2
2.7
24.53
31.93
u/l
2.41
60
379
30
147
2.08
3.36
9.2
5.8
88.80
98.86
%
1.31
30
147
212
2556
0.73
3.31
2.1
2.1
—
—
—
0
0
32
162
2.01
3.29
3.4
3.8
657.79
494.82
e6/l
0.69
24
103
92
633
1.52
3.22
2.8
2.1
—
—
—
0
0
37
199
1.90
3.21
2.4
5.0
33.50
298.72
e6/l
1.34
28
131
18
72
2.53
3.19
2.9
4.9
0.39
0.76
index
1.53
18
72
37
200
1.89
3.17
2.3
5.0
8.88
6.17
e6/l
0.15
25
128
31
158
2.00
3.14
3.8
4.1
—
—
—
0
0
32
165
1.98
3.14
3.6
3.8
278.17
190.60
e6/l
0.62
24
107
330
2833
1.33
3.14
5.8
4.0
163.40
1627.97
e6/l
—
10
32
109
783
1.46
3.09
3.0
2.2
59.42
37.69
ng/l
0.33
58
297
282
2375
1.33
3.03
4.5
3.7
0.00
2.85
estimate
0.50
28
431
36
197
1.86
2.98
2.1
4.7
3.22
3.35
mmol/l
0.79
36
191
9
241
0.36
2.98
1.4
1.6
81.34
59.05
ug/l
—
9
241
280
2360
1.32
2.97
4.5
3.7
0.00
0.00
estimate
-0.00
30
449
19
82
2.34
2.89
1.5
1.3
6.42
3.50
u/ml
0.24
12
36
492
5201
0.71
2.88
3.8
4.0
—
—
—
0
0
29
151
1.95
2.79
1.7
1.6
5.55
6.60
ug/l
0.20
29
141
37
210
1.80
2.75
3.4
2.1
—
—
—
0
0
280
2379
1.31
2.74
4.6
3.7
0.00
0.00
estimate
-0.00
28
431
31
167
1.89
2.71
5.3
8.6
24.27
24.31
mmol/l
0.02
31
157
39
227
1.75
2.67
1.6
1.7
—
—
—
0
0
38
221
1.75
2.62
3.9
2.3
—
—
—
0
0
26
134
1.97
2.59
3.1
1.9
—
—
—
0
0
12
44
2.74
2.52
8.9
10.6
—
—
—
0
0
12
44
2.74
2.52
1.2
1.1
—
—
—
0
0
11
267
0.40
2.51
1.7
1.7
—
—
—
0
0
10
31
3.24
2.50
3.8
6.5
151.60
201.29
ug/l
—
10
31
35
203
1.75
2.44
13.7
12.1
1111.20
448.64
iu/ml
—
5
25
27
145
1.89
2.40
2.6
2.0
—
—
—
0
0
42
259
1.65
2.37
1.5
1.5
990.59
1093.30
nmol/l
0.31
32
208
10
34
2.95
2.27
3.7
2.4
13.79
17.72
umol/l
—
10
34
38
231
1.67
2.27
4.0
3.2
14.47
18.83
mu/l
0.93
38
221
36
567
0.61
2.24
1.2
1.4
3.58
3.46
ratio
0.26
22
379
23
120
1.94
2.24
1.6
1.4
—
—
—
0
0
46
295
1.59
2.23
1.8
1.7
0.21
0.22
mg/l
0.07
19
142
17
80
2.14
2.16
1.1
1.3
94.35
107.73
%
0.63
17
75
166
1360
1.29
2.04
4.0
3.3
2.58
2.41
mg/l
0.59
151
1212
16
76
2.12
2.00
5.8
6.0
—
—
—
0
0
27
155
1.76
1.99
2.7
1.9
—
—
—
0
0
18
328
0.53
1.93
1.7
1.7
—
—
—
0
0
6
16
3.75
1.92
3.7
2.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
64
2.20
1.92
1.4
1.2
—
—
—
0
0
13
58
2.25
1.89
2.8
1.7
164.23
126.71
%
0.94
13
58
19
99
1.93
1.88
1.1
1.1
—
—
—
0
0
21
114
1.86
1.85
5.8
5.9
2.51
2.00
ug/l
0.38
21
114
19
100
1.91
1.84
4.5
2.6
1.73
2.12
mmol/l
0.35
11
84
602
5824
1.75
1.83
30.5
18.2
268.08
266.56
e9/l
0.22
588
5606
543
5151
1.36
1.83
18.7
12.1
23.48
22.55
mg/l
0.25
443
3742
38
562
0.65
1.82
1.4
1.6
—
—
—
0
0
29
455
0.61
1.81
1.2
1.3
3.25
3.26
mmol/l
0.02
17
269
12
53
2.27
1.79
1.2
1.1
—
—
—
0
0
71
524
1.39
1.77
4.3
4.9
5.60
40.31
mg/mmol
0.71
46
420
13
60
2.18
1.76
1.5
1.2
—
—
—
0
0
29
177
1.66
1.75
14.3
21.1
72.17
69.92
%
0.24
29
177
14
67
2.10
1.74
1.1
1.1
—
—
—
0
0
38
556
0.66
1.74
1.5
1.6
1529.87
945.51
mu/l
0.41
29
507
602
5830
1.72
1.73
30.4
18.1
4.72
4.69
e12/l
0.80
584
5599
137
1118
1.28
1.73
4.0
3.6
0.00
0.00
estimate
0.50
29
419
26
155
1.69
1.71
2.3
1.6
—
—
—
0
0
20
111
1.82
1.67
1.6
1.5
—
—
—
0
0
7
25
2.80
1.64
2.0
2.3
—
—
—
0
0
16
83
1.94
1.63
21.6
10.0
9.88
9.23
mg/l
0.13
16
77
29
181
1.62
1.62
2.6
3.8
85.21
88.47
ml/min/173m2
—
7
53
11
49
2.25
1.62
1.0
1.0
—
—
—
0
0
61
448
1.39
1.58
10.6
7.5
263.08
300.13
u/l
0.87
61
440
7
26
2.69
1.57
1.0
1.6
—
—
—
0
0
10
44
2.28
1.55
26.2
8.5
1.21
1.24
mmol/l
—
10
39
17
92
1.86
1.54
42.9
36.3
158.59
146.13
ug/l
0.21
17
85
24
145
1.67
1.52
1.3
1.4
317.12
379.93
ug/g
0.94
17
79
64
478
1.37
1.51
1.7
1.3
137.80
130.93
u/ml
0.04
12
153
14
72
1.95
1.47
1.1
1.1
—
—
—
0
0
13
65
2.01
1.47
1.0
1.1
—
—
—
0
0
13
65
2.01
1.47
2.9
2.1
20.80
19.71
nmol/l
—
5
17
151
1751
0.81
1.46
2.9
2.7
—
—
—
0
0
10
45
2.23
1.44
4.8
5.0
5.38
4.85
kpa
—
10
45
11
52
2.12
1.42
2.5
5.6
18.19
23.68
ug/l
1.14
11
52
6
22
2.72
1.42
1.0
1.3
108.83
106.82
%
—
6
22
6
22
2.72
1.42
3.7
3.5
—
—
—
0
0
32
214
1.51
1.37
1.3
1.1
—
—
—
0
0
5
17
2.94
1.35
1.4
1.4
13.20
9.96
mmol/l
—
5
17
353
3239
1.19
1.35
5.5
4.6
8.25
6.81
mm/h
1.70
337
3044
13
68
1.92
1.31
1.5
1.2
—
—
—
0
0
239
2125
1.19
1.30
2.0
1.8
1.68
1.66
g/l
0.09
124
1165
5
18
2.77
1.27
3.6
1.3
252.20
191.89
u/l
—
5
18
9
44
2.05
1.26
1.7
1.1
72.78
75.55
%
—
9
44
9
44
2.05
1.26
1.7
1.1
672.11
381.75
mu/l
—
9
44
17
101
1.69
1.18
2.0
1.5
—
—
—
0
0
8
38
2.10
1.18
3.1
2.1
102.00
98.42
g/l
—
8
38
11
57
1.93
1.15
6.5
7.7
—
—
—
0
0
27
183
1.49
1.12
1.4
1.4
—
—
—
0
0
27
183
1.49
1.12
1.4
1.4
—
—
—
0
0
12
65
1.85
1.12
10.3
10.4
—
421.23
—
0
13
19
119
1.60
1.10
2.9
1.6
—
—
—
0
0
13
215
0.59
1.07
1.0
1.1
—
8.12
—
0
29
9
45
2.00
1.05
2.1
1.2
—
—
—
0
0
20
129
1.56
1.04
3.8
4.8
8.10
15.61
u/ml
0.50
20
129
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
12
67
1.79
1.03
3.1
1.8
138.83
121.66
%
0.36
12
67
324
2994
1.16
1.03
6.4
4.4
36.03
28.73
u/l
1.74
319
2894
35
256
1.38
0.99
2.3
2.1
—
—
—
0
0
22
147
1.50
0.99
2.2
2.3
2.23
3.87
iu/l
—
7
70
147
1652
0.85
0.99
2.6
2.6
—
—
—
0
0
30
407
0.72
0.98
1.5
1.3
—
—
—
0
0
34
248
1.38
0.98
3.3
2.0
30.04
31.67
%
0.35
23
192
14
84
1.67
0.96
3.1
3.9
18.66
18.02
%
0.37
14
79
12
69
1.74
0.95
3.0
1.6
—
—
—
0
0
6
115
0.51
0.95
1.7
2.0
—
—
—
0
0
8
44
1.82
0.85
1.1
1.1
—
—
—
0
0
41
317
1.30
0.84
2.9
2.3
121.37
103.09
au/ml
0.41
19
122
6
31
1.93
0.84
3.0
2.0
3.42
1.67
nmol/l
—
6
31
6
31
1.93
0.84
2.2
1.3
—
—
—
0
0
291
2699
1.13
0.82
4.4
3.7
62.17
60.39
ug/l
0.09
281
2581
6
32
1.87
0.81
1.0
2.2
10.52
9.97
g/l
—
6
32
11
174
0.62
0.79
1.8
1.8
14.87
9.78
u/ml
—
6
52
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
19
132
1.44
0.74
5.1
8.4
65.76
443.61
mg/mmol
0.55
14
124
5
24
2.08
0.74
1.4
1.8
—
—
—
0
0
16
229
0.69
0.74
1.7
1.5
0.00
0.09
iu/ml
—
7
46
14
91
1.54
0.73
2.9
1.7
—
—
—
0
0
109
1224
0.86
0.73
3.6
2.9
0.00
0.00
estimate
0.50
20
364
176
1594
1.13
0.71
3.7
3.1
0.00
0.01
estimate
0.80
22
375
32
405
0.77
0.70
1.3
1.2
—
4.73
—
0
24
16
109
1.47
0.69
1.9
2.5
—
—
—
0
0
10
61
1.64
0.67
1.2
1.2
—
—
—
0
0
17
231
0.72
0.61
1.4
1.3
—
—
—
0
0
8
52
1.53
0.59
3.1
2.6
1.64
3.48
nmol/l
—
8
46
17
122
1.39
0.58
1.1
1.2
—
—
—
0
0
52
608
0.84
0.58
1.3
1.2
13.08
15.09
iu/ml
0.20
11
112
6
35
1.71
0.57
1.5
1.4
—
—
—
0
0
6
35
1.71
0.57
1.0
2.2
3.37
3.60
g/l
—
6
35
6
35
1.71
0.57
1.5
1.4
—
—
—
0
0
6
35
1.71
0.57
1.5
1.4
—
—
—
0
0
6
35
1.71
0.57
1.0
2.2
4.48
4.07
g/l
—
6
35
6
35
1.71
0.57
1.0
2.2
7.63
7.37
g/l
—
6
35
6
35
1.71
0.57
1.0
2.2
2.65
3.07
g/l
—
6
35
29
358
0.79
0.55
1.5
1.5
—
—
—
0
0
9
59
1.52
0.55
3.2
2.0
—
—
—
0
0
9
62
1.45
0.53
1.7
2.0
—
—
—
0
0
33
399
0.81
0.52
1.4
1.4
—
—
—
0
0
6
40
1.49
0.51
1.0
1.2
—
—
—
0
0
7
47
1.48
0.47
1.3
1.7
8.41
7.00
mmol/l
—
7
42
8
119
0.66
0.46
1.3
1.2
—
—
—
0
0
13
94
1.38
0.44
3.0
1.7
—
—
—
0
0
9
126
0.71
0.43
1.7
2.0
—
—
—
0
0
5
32
1.56
0.42
1.0
2.2
0.00
0.00
g/l
—
5
32
5
32
1.56
0.42
1.0
2.2
0.00
0.00
g/l
—
5
32
12
160
0.74
0.41
1.2
1.5
52.37
16.45
u/ml
—
7
132
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
50
566
0.87
0.41
1.2
1.2
0.99
4.56
u/ml
2.05
19
183
12
87
1.38
0.41
1.8
1.4
—
—
—
0
0
5
34
1.46
0.40
1.0
1.5
—
—
—
0
0
21
257
0.80
0.39
3.5
2.2
—
—
—
0
0
5
35
1.42
0.39
1.0
2.2
0.00
0.13
g/l
—
5
35
5
35
1.42
0.39
1.0
2.2
0.00
0.00
g/l
—
5
35
8
115
0.69
0.37
1.4
1.5
—
—
—
0
0
6
41
1.46
0.36
1.0
1.0
2403.67
1596.39
miu/ml
—
6
41
6
42
1.42
0.35
1.0
1.1
—
—
—
0
0
17
209
0.80
0.34
2.1
1.9
—
—
—
0
0
6
87
0.68
0.33
1.2
1.3
81.33
78.51
%
—
6
87
6
46
1.30
0.33
1.3
1.2
—
—
—
0
0
13
161
0.80
0.28
1.6
1.1
—
—
—
0
0
18
148
1.21
0.28
4.3
3.3
—
—
—
0
0
28
241
1.16
0.27
1.0
1.0
9.02
8.85
mu/l
0.05
22
209
20
169
1.18
0.24
1.9
1.9
—
—
—
0
0
13
157
0.82
0.24
1.6
1.1
—
—
—
0
0
5
37
1.34
0.23
2.8
1.7
—
—
—
0
0
24
272
0.87
0.23
1.5
1.6
61.48
60.18
ug/l
0.04
19
240
5
39
1.28
0.22
2.6
1.6
—
1225620.00
iu/ml
—
0
5
0
10
0.00
0.21
0.0
2.4
—
2.73
—
0
10
0
10
0.00
0.21
0.0
1.5
—
1.18
—
0
10
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
5
42
1.18
0.21
1.0
1.3
—
—
—
0
0
5
42
1.18
0.21
1.0
1.3
—
—
—
0
0
5
42
1.18
0.21
1.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
6
47
1.27
0.20
1.3
1.2
—
—
—
0
0
6
50
1.19
0.19
1.3
1.4
—
—
—
0
0
78
732
1.07
0.18
1.1
1.1
—
—
—
0
0
8
68
1.17
0.16
1.1
1.2
—
—
—
0
0
8
71
1.12
0.16
1.3
1.2
—
—
—
0
0
6
76
0.78
0.15
1.0
1.1
29.35
32.03
iu/ml
—
6
76
11
127
0.86
0.13
1.1
1.3
—
2.19
—
0
10
11
127
0.86
0.13
1.2
1.3
—
23.25
—
0
15
37
342
1.08
0.13
1.1
1.1
6.63
11.50
u/ml
0.75
23
229
14
156
0.89
0.11
1.3
1.3
—
—
—
0
0
5
45
1.10
0.09
1.0
1.3
—
—
—
0
0
5
45
1.10
0.09
1.0
1.3
—
—
—
0
0
231
2258
1.03
0.09
1.7
1.9
0.43
3.24
u/ml
6.43
44
422
23
244
0.93
0.08
1.5
1.5
1.14
1.18
ratio
—
10
150
23
244
0.93
0.08
1.5
1.5
1.21
1.21
ratio
—
10
150
23
244
0.93
0.08
1.5
1.5
0.95
0.91
ratio
—
10
150
7
68
1.02
0.07
1.1
1.2
—
—
—
0
0
6
71
0.84
0.07
3.5
3.1
14.83
32.92
u/ml
—
6
59
8
76
1.05
0.07
13.3
9.3
5.30
5.60
pmol/l
—
8
76
7
83
0.84
0.07
1.6
1.6
—
—
—
0
0
22
233
0.94
0.07
1.5
1.5
—
—
—
0
0
12
131
0.91
0.06
1.1
1.2
—
38.33
—
0
7
36
373
0.96
0.06
1.6
1.8
—
—
—
0
0
38
363
1.04
0.05
1.2
1.1
5.08
8.03
u/ml
0.50
25
253
46
443
1.03
0.04
1.5
1.3
—
—
—
0
0
94
949
0.98
0.04
2.4
2.3
—
—
—
0
0
43
415
1.03
0.04
2.8
2.0
—
40.95
—
0
6
13
121
1.07
0.03
2.7
3.2
135.00
136.58
g/l
0.12
13
106
51
517
0.98
0.03
1.1
1.2
4.29
3.17
u/ml
0.26
39
385
20
190
1.05
0.02
1.0
1.0
3.07
3.24
kpa
0.15
13
162
30
289
1.03
0.02
1.3
1.5
—
—
—
0
0
33
335
0.98
0.01
1.5
1.3
278.23
247.60
miu/ml
0.17
15
164
42
410
1.02
0.01
2.8
2.1
171.43
174.44
u/ml
0.02
23
199
55
540
1.01
0.00
3.0
2.6
7591.77
5560.39
u/l
0.13
13
193
20
193
1.03
0.00
1.0
1.0
7.06
7.35
kpa
0.23
13
165
20
193
1.03
0.00
1.0
1.0
-0.80
-2.46
mmol/l
—
6
36
107
1068
0.99
0.00
2.8
2.5
—
—
—
0
0
34
334
1.01
0.00
1.1
1.1
0.57
0.90
u/ml
0.26
21
189
20
196
1.01
0.00
1.4
1.6
19.50
11.92
u/ml
0.15
14
135
58
572
1.01
0.00
1.2
1.3
3.61
2.80
u/ml
0.23
43
423
53
529
0.99
0.00
1.1
1.3
4.40
6.58
u/ml
0.64
37
408
10
100
0.99
0.00
1.5
1.3
0.41
0.43
ug/l
—
5
23
53
525
1.00
0.00
1.1
1.2
1.38
1.16
u/ml
0.12
37
376
11
109
1.00
0.00
1.0
1.3
—
1.41
—
0
8
119
1181
1.00
0.00
3.4
3.5
87.34
110.42
ug/g
0.62
97
970
6
67
0.89
-0.00
1.3
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
4.74
—
0
5
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
7
71
0.98
-0.00
5.7
5.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
6
64
0.93
-0.00
3.0
2.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
4.9
—
135.75
—
0
8
8
83
0.96
-0.00
1.0
1.0
168.75
162.80
g/l
—
8
83
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
273.20
—
0
5
7
69
1.01
-0.00
1.1
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
11.06
—
0
5
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
6
68
0.87
-0.00
1.2
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
1.19
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
120.50
—
0
6
6
67
0.89
-0.00
1.2
1.2
—
—
—
0
0
7
71
0.98
-0.00
5.7
5.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: KRA_PSY_MOTOR – Motor disorders
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).